256 related articles for article (PubMed ID: 29282809)
1. Serious hazards of transfusion - conference report: celebration of 20 years of UK haemovigilance.
Bolton-Maggs PHB
Transfus Med; 2017 Dec; 27(6):393-400. PubMed ID: 29282809
[TBL] [Abstract][Full Text] [Related]
2. Conference report: International Haemovigilance Seminar and the SHOT Annual Symposium, 10-12 July 2018.
Bolton-Maggs PHB
Transfus Med; 2019 Aug; 29(4):247-252. PubMed ID: 30592099
[TBL] [Abstract][Full Text] [Related]
3. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents.
Bolton-Maggs PH
Transfus Med; 2016 Dec; 26(6):401-405. PubMed ID: 27995700
[TBL] [Abstract][Full Text] [Related]
4. Haemovigilance: an effective tool for improving transfusion practice.
de Vries RR; Faber JC; Strengers PF;
Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
[TBL] [Abstract][Full Text] [Related]
5. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety.
Bolton-Maggs PH; Cohen H
Br J Haematol; 2013 Nov; 163(3):303-14. PubMed ID: 24032719
[TBL] [Abstract][Full Text] [Related]
6. Systems contributing to the assurance of transfusion safety in the United Kingdom.
Williamson LM
Vox Sang; 1999; 77(2):82-7. PubMed ID: 10516552
[TBL] [Abstract][Full Text] [Related]
7. Transfusion errors - can they be eliminated?
Bolton-Maggs PHB; Watt A
Br J Haematol; 2020 Apr; 189(1):9-20. PubMed ID: 31792932
[TBL] [Abstract][Full Text] [Related]
8. 6 Years of shot reporting--its influence on UK blood safety.
Stainsby D; Williamson L; Jones H; Cohen H
Transfus Apher Sci; 2004 Oct; 31(2):123-31. PubMed ID: 15501416
[TBL] [Abstract][Full Text] [Related]
9. International haemovigilance: what have we learned and what do we need to do next?
Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
[TBL] [Abstract][Full Text] [Related]
10. Efforts Toward Elimination of Infectious Agents in Blood Products.
Jacquot C; Delaney M
J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
[TBL] [Abstract][Full Text] [Related]
11. Conference report: the 2015 SHOT symposium and report--what's new?
Bolton-Maggs PH
Transfus Med; 2015 Oct; 25(5):295-8. PubMed ID: 26498582
[No Abstract] [Full Text] [Related]
12. Hemovigilance drives improved transfusion safety.
Murphy MF
Transfusion; 2021 Apr; 61(4):1333-1335. PubMed ID: 33831223
[No Abstract] [Full Text] [Related]
13. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
[TBL] [Abstract][Full Text] [Related]
14. Eight years with haemovigilance in Norway. What have we learnt?
Steinsvåg CT; Espinosa A; Flesland Ø
Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
[TBL] [Abstract][Full Text] [Related]
15. Direct costs of transfusion reactions - an expert judgement approach.
Janssen MP; van Tilborgh AJW; de Vooght KMK; Bokhorst AG; Wiersum-Osselton JC
Vox Sang; 2018 Feb; 113(2):143-151. PubMed ID: 29124766
[TBL] [Abstract][Full Text] [Related]
16. Serious hazards of transfusion: a decade of hemovigilance in the UK.
Stainsby D; Jones H; Asher D; Atterbury C; Boncinelli A; Brant L; Chapman CE; Davison K; Gerrard R; Gray A; Knowles S; Love EM; Milkins C; McClelland DB; Norfolk DR; Soldan K; Taylor C; Revill J; Williamson LM; Cohen H;
Transfus Med Rev; 2006 Oct; 20(4):273-82. PubMed ID: 17008165
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016.
Politis C; Wiersum-Osselton J; Richardson C; Grouzi E; Sandid I; Marano G; Goto N; Condeço J; Boudjedir K; Asariotou M; Politi L; Land K
Transfus Clin Biol; 2022 Aug; 29(3):243-249. PubMed ID: 35476961
[TBL] [Abstract][Full Text] [Related]
18. ABO incompatible transfusions--experience from the UK Serious Hazards of Transfusion (SHOT) scheme Transfusions ABO incompatible.
Stainsby D
Transfus Clin Biol; 2005 Nov; 12(5):385-8. PubMed ID: 16325447
[TBL] [Abstract][Full Text] [Related]
19. Acute blood transfusion reactions in a tertiary care hospital in Pakistan - an initiative towards haemovigilance.
Borhany M; Anwar N; Tariq H; Fatima N; Arshad A; Naseer I; Shamsi T
Transfus Med; 2019 Aug; 29(4):275-278. PubMed ID: 29845667
[TBL] [Abstract][Full Text] [Related]
20. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force.
Tinegate H; Birchall J; Gray A; Haggas R; Massey E; Norfolk D; Pinchon D; Sewell C; Wells A; Allard S;
Br J Haematol; 2012 Oct; 159(2):143-53. PubMed ID: 22928769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
